Atlas Trials

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

Clinical trial NCT02559973 · COMPLETED

Trial details

NCT number
NCT02559973
Sponsor
Indivior Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Opioid Use Disorder
Start date
2015-09-01
Primary completion
2016-02-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.